Glycemic Variability of Combination Therapies in T2DM

This study is comparing different medication combinations in people with type 2 diabetes who are not achieving adequate blood sugar control despite already taking metformin and an SGLT-2 inhibitor (two common diabetes medications). Researchers are looking at how different add-on therapies affect blood sugar variability throughout the day. **You may be eligible if...** - You have type 2 diabetes - You are already taking metformin (at least 1,000 mg per day) and an SGLT-2 inhibitor (such as empagliflozin or dapagliflozin) - Your blood sugar is still not well controlled despite these medications **You may NOT be eligible if...** - You have a history of lactic acidosis or metabolic acidosis (a dangerous build-up of acid in the blood) - You have moderate to severe kidney disease (eGFR below 45) - You have severe liver problems - You have advanced heart failure (NYHA Class III or IV) Talk to your doctor to see if this trial is right for you.